Basics Rapport Therapeutics, Inc. Common Stock IPO Date: June 7, 2024 Sector: Healthcare Industry: Biotech Market Cap: $343.08M Activated in VL: True Average Daily Range Avg Daily Range: $0.86 | 5.01% Avg Daily Range (30 D): $0.51 | 4.88% Avg Daily Range (90 D): $0.59 | 5.63% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .16M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 53 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $.89M Avg Inst. Trade (90 D): $1.4M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.31M Avg Closing Trade (30 D): $1.68M Avg Closing Trade (90 D): $2.25M Avg Closing Volume: 206.26K     News Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc. Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A Sep 5, 2024 @ 11:00 AM Rapport Therapeutics to Present at Upcoming Epilep... Source: N/A Aug 29, 2024 @ 11:00 AM Rapport Therapeutics to Present at 22nd Annual Mor... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3 $-.68 $-.12 Diluted EPS $-3 $-.68 $-.12 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -79.7M $ -24.06M $ -19.98M Operating Income / Loss $ -93.07M $ -27.11M $ -23.52M Cost of Revenue $ $ $ Net Cash Flow $ -16.66M $ .8M $ 17.49M PE Ratio